In liver biopsies from patients with nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma, both CCR3 and CCL24 were found to be hyperexpressed, and high CCR3 expression in hepatic fibroblasts was demonstrated in both liver diseases (30, 31). Here, CCL24 is linked to metabolic dysfunction-associated steatohepatitis.